GlassScriptPhysician profile
Azadeh Akhavan
NPI 1811311962
$11,335.12
in general payments reported to CMS, 2019-2025
8 companies · $2,299 in 2025
The $2,299 reported for 2025 was more than what 98% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.58 · 2020: $368 · 2022: $17.82 · 2023: $79.51 · 2024: $8,496 · 2025: $2,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $10K · Food and Beverage: $220 · Consulting Fee: $175 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $10,428.78 |
| Food and Beverage | $220.24 |
| Consulting Fee | $175.00 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $10,038.30 | 2024-2025 | |
| Align Technology, INC. | $460.64 | 2020-2025 | Invisalign, Itero, Itero Element |
| Ultradent Products INC | $390.48 | 2025 | Opalescence |
| Straumann USA LLC | $267.82 | 2019-2022 | |
| Zimvie INC. | $122.23 | 2025 | |
| Neoss, INC. | $27.31 | 2023 | Neoss Implant System |
| Voco America INC. | $15.26 | 2023 | Meron Plus Qm, Admira Fusion X-Tra, Futurabond U |
| Dentsply Sirona Orthodontics INC | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azadeh Akhavan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.